Effect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study

Affiliation auteurs!!!! Error affiliation !!!!
TitreEffect of Prior Therapy on the Efficacy and Safety of Oral Selinexor in Patients with Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis of the Sadal Study
Type de publicationJournal Article
Year of Publication2019
AuteursCavallo F, Follows GA, Goy A, Vermaat J, Casasnovas R-O, Lavee O, Maerevoet M, Zijlstra JM, Bakhshi S, Bouabdallah R, Choquet S, Gurion R, Hill BT, Jaeger U, Sancho J-M, Schuster MW, Thieblemont C, De la Cruz F, Egyed M, Mishra S, Offner F, Vassilakopoulos TP, Warzocha K, McCarthy D, Ma X, Corona K, Saint-Martin J-R, Joshi A, Shah J, Van Den Neste E, Canales MA, Kalakonda N
JournalBLOOD
Volume134
Date PublishedNOV 13
Type of ArticleMeeting Abstract
ISSN0006-4971
DOI10.1182/blood-2019-122900